» Articles » PMID: 8551266

Comparison of Human Immunodeficiency Virus Biological Phenotypes Isolated from Cerebrospinal Fluid and Peripheral Blood

Overview
Journal J Med Virol
Specialty Microbiology
Date 1995 Sep 1
PMID 8551266
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Quantitative human immunodeficiency virus (HIV) cultures were carried out on cerebrospinal fluid (CSF), peripheral blood mononuclear cells (PBMCs), and plasma from patients with HIV in order to compare the infectious HIV load. The HIV strains isolated were studied for syncytium-inducing (SI) capacity, using the MT-2 cell line, in order to compare the HIV strain phenotype of blood and CSF isolates. Forty-two patients with HIV-1 infection were enrolled in the study, 33 of whom had neurological symptoms and 9 of whom were without neurological symptoms. HIV was isolated from 16 (38%) of the 42 CSF cultures, with a low mean titer of 6.3 +/- 3.4 tissue-culture-infective doses (TCID) per milliliter. Patients with HIV-positive CSF culture had a viral load in PBMCs of 40.5 +/- 15.5 TCID per 10(6) PBMC and in plasma of 104.7 +/- 9.3 per milliliter. Two (15%) of the 13 CSF isolates were SI strains, compared to 17 (56.6%) of the 30 PBMC isolates and 13 (54%) of the 24 plasma isolates (P < 0.05). Five of the nine patients from whom CSF and blood strains were obtained had the same viral biological phenotype. This study suggests that different HIV variants may be found in different body fluids and/or cells.

Citing Articles

Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy.

McMahon D, Jones J, Wiegand A, Gange S, Kearney M, Palmer S Clin Infect Dis. 2010; 50(6):912-9.

PMID: 20156060 PMC: 2897152. DOI: 10.1086/650749.


Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy.

Dinoso J, Kim S, Wiegand A, Palmer S, Gange S, Cranmer L Proc Natl Acad Sci U S A. 2009; 106(23):9403-8.

PMID: 19470482 PMC: 2685743. DOI: 10.1073/pnas.0903107106.


Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease.

Arendt G, Nolting T, Frisch C, Husstedt I, Gregor N, Koutsilieri E J Neurovirol. 2007; 13(3):225-32.

PMID: 17613712 DOI: 10.1080/13550280701315355.


Cerebrospinal fluid HIV viral load in different phases of HIV-associated brain disease.

Giesen H, Adams O, Koller H, Arendt G J Neurol. 2005; 252(7):801-7.

PMID: 15750706 DOI: 10.1007/s00415-005-0749-4.